Updated software improves slicing for large-format 3D printing
The common sounds in the background of daily life – like a refrigerator’s hum, an air conditioner’s whoosh and a heat pump’s buzz – often go unnoticed. These noises, however, are the heartbeat of a healthy building and integral for comfort and convenience.
In June, ORNL hit a milestone not seen in more than three decades: producing a production-quality amount of plutonium-238
Oak Ridge National Laboratory researchers are taking fast charging for electric vehicles, or EVs, to new extremes. A team of battery scientists recently developed a lithium-ion battery material that not only recharges 80% of its capacity in 10
The Exascale Small Modular Reactor effort, or ExaSMR, is a software stack developed over seven years under the Department of Energy’s Exascale Computing Project to produce the highest-resolution simulations of nuclear reactor systems to date. Now, ExaSMR has been nominated for a 2023 Gordon Bell Prize by the Association for Computing Machinery and is one of six finalists for the annual award, which honors outstanding achievements in high-performance computing from a variety of scientific domains.
Cadet Elyse Wages, a rising junior at the United States Air Force Academy, visited ORNL with one goal in mind: collect air.
Neutron experiments can take days to complete, requiring researchers to work long shifts to monitor progress and make necessary adjustments. But thanks to advances in artificial intelligence and machine learning, experiments can now be done remotely and in half the time.
Rose Montgomery, a distinguished researcher and leader of the Used Fuel and Nuclear Material Disposition group at ORNL, has been selected to participate in the U.S. WIN Nuclear Executives of Tomorrow, or NEXT, class of 2023 to 2024.
Technologies developed by researchers at ORNL have received six 2023 R&D 100 Awards.
A group at the Department of Energy's Oak Ridge National Laboratory made a difference for local youth through hands-on projects that connected neutron science and engineering intuitively.
After a highly lauded research campaign that successfully redesigned a hepatitis C drug into one of the leading drug treatments for COVID-19, scientists at ORNL are now turning their drug design approach toward cancer.